Financhill
Back

Novo Nordisk AS Stock Predictions

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 20.2% based on the past 43 years of stock performance.
  • Novo Nordisk AS has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NVO] share price is $101.74. The Score for NVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 20.2% based on the past 43 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
33
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%

Novo Nordisk AS Stock Price History

Is NVO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
148.15
52-Week Low:
94.73

Prediction Charts

Market Cap:
452.1B
Price in USD:
101.74
Volume:
8.05M
Beta:
0.49

Technical Analysis

SMA50:
118.58
SMA100:
126.77
SMA200:
128.19
52-Wk Change:
5.51%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 101.74 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 111.62 111.98 113.27 111.15
Oct-30 108.89 113.24 113.76 107.24
Oct-31 110.21 111.95 112.16 109.63
Nov-1 112.88 111.94 113.02 111.79
Nov-4 110.19 109.72 110.66 109.44
Nov-5 107.98 110.13 110.30 107.75
Nov-6 108.27 105.36 108.75 105.03
Nov-7 106.10 107.63 107.74 105.59
Nov-8 107.15 107.20 107.87 106.43
Nov-11 109.70 109.09 110.61 108.93
Nov-12 106.81 107.06 107.61 105.70
Nov-13 106.88 106.91 107.79 106.55
Nov-14 106.83 105.32 107.00 105.00
Nov-15 101.67 101.74 102.34 100.32

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.